Anthropic Nears $83 Issue Price: What Events to Watch Next?
Anthropic shares recently hovered near their $83 IPO price, facing upcoming catalysts including MSCI index inclusion on December 1, subsequent Russell and Nasdaq milestones, and heavy share lock-up expirations. While nine-month revenue surged 1,200% year-over-year to $33.2 billion, sequential growth moderated and operating results turned to a loss. Key investor focus areas include fourth-quarter earnings stabilization, the market's capacity to absorb substantial upcoming share unlocks, and cash flow impacts from heavy contractual computing payments projected through late 2027.

TradingKey - On November 20 ET, Anthropic (ANT) fell intraday to as low as $83.05 on its second day of trading, just $0.05 away from its $83 IPO price. Looking ahead, investors can keep three key milestones in mind: on December 1, MSCI inclusion takes effect; on December 15, the lock-up expires on the next tranche of up to 303 million shares; and between February and March 2027, the company is expected to report its first post-IPO full-year results, followed by a lock-up expiration window for up to approximately 1.7 billion shares.
Index Inclusion Timing: Three Windows in December
Following index inclusion, funds tracking the index will need to allocate to Anthropic stock according to its weighting; therefore, related buying may emerge in tranches across December. December 14 and 15 are particularly worth noting. If the Russell indices include Anthropic under the aforementioned arrangement, a new batch of shares will become eligible for sale on the trading day after funds complete their rebalancing. It will then be possible to observe whether the market can absorb the shares actually sold by early shareholders once the rebalancing buying subsides.
Eastern Time | Index Event | Confirmation Status |
December 1, 2026 | Anthropic Class A shares included in the Large Cap segment of the MSCI Global Standard Index | Confirmed; adjustment takes effect after the close on November 30. |
After the close on December 11 | Russell US Equity Indexes semi-annual reconstitution, effective at the open on December 14 | FTSE Russell's announcement specifies that Anthropic must meet fast-entry criteria. |
Before the open on December 21 | Anthropic may be included in the Nasdaq 100 Index | Window estimated based on index rules, pending official confirmation. |
If Anthropic is subsequently included in the Nasdaq 100 Index, funds such as QQQ will also allocate to it based on its initial weighting. Because a significant number of shares remain locked up, the market capitalization used by Nasdaq to calculate its weighting is capped at three times its eligible free-float market capitalization.
Share Lock-Up Expiry Schedule: 23 Key Dates From Listing Debut to November 2027
U.S. Eastern Time or Trigger Condition | Maximum Additional Shares Eligible for Sale per Tranche | Applicable Arrangement |
November 19, 2026 (First Day of Trading) | 315 million shares | Non-founder directors, executive officers, and certain current employees, former employees, and consultants may sell up to 10% of their restricted holdings |
December 15, 2026, and January 5, 2027 | 303 million shares each | First two scheduled lock-up releases following the IPO |
January 19 and February 2, 2027 | 353 million shares each | Subsequent two scheduled lock-up releases |
Second full trading day following the release of fiscal 2026 earnings | Approximately 1.7 billion shares | Individuals subject to the first-day 10% unlock arrangement may sell up to an additional 35% of their restricted holdings |
Days 13, 27, 41, 55, and 69 following the release of full-year earnings | 480 million shares each | Released in five tranches |
Second full trading day following the Q1 2027 earnings release, or after market close on May 17, whichever is earlier | Approximately 3 billion shares | The largest single tranche, allowing the seven co-founders to sell up to 29% of their restricted holdings for the first time |
Days 34, 48, 62, and 76 following the release of Q1 earnings | 447 million shares each | Released in four tranches |
Second full trading day following the release of Q2 2027 earnings | 558 million shares | First lock-up release triggered by Q2 earnings |
Days 27, 41, 55, 69, and 83 following the release of Q2 earnings | 502 million shares each | Released in five tranches |
Second full trading day following the Q3 2027 earnings release, or after market close on November 18, whichever is earlier | Approximately 1.9 billion shares | Remaining restricted holdings of the founders and other shares become unlocked |
Share numbers in the table represent the combined total of Class A and Class N shares, with tranches of identical size consolidated. Day-count milestones are based on calendar days, rolling over to the next trading day if falling on a non-trading day. May 17 and November 18 correspond to the 180th and 365th days following the date of the final prospectus, respectively.
Staggered lock-up expirations distribute newly tradable shares across one year, but two tranches are particularly concentrated. Following the release of full-year earnings, up to approximately 1.7 billion shares will become eligible for sale, forcing the market to simultaneously absorb shifting earnings expectations and shareholder selling pressure. Around May 2027, the cap for a single tranche increases to approximately 3 billion shares, marking the first window in which the founders can sell a portion of their restricted holdings.
Earnings Schedule: First Full-Year Results Expected in February to March 2027
The following months represent estimated disclosure windows based on fiscal quarter-end dates.
Estimated Disclosure Window | Earnings Milestone | Key Focus Areas |
February to March 2027 | Fourth-Quarter and Full-Year 2026 Financial Results | Whether fourth-quarter sequential revenue growth stabilizes and operating profit returns to positive territory |
Late April to May 2027 | First-Quarter 2027 Financial Results | Whether enterprise customer spending continues to grow and whether the lock-up expiration window for approximately 3 billion shares is moved forward |
Late July to August 2027 | Second-Quarter 2027 Financial Results | Whether first-half revenue growth translates into cash and the extent to which computing payments impact free cash flow |
Late October to November 2027 | Third-Quarter 2027 Financial Results | Assess prior contractual payment estimates against actual cash expenditures through the end of September |
In the first post-IPO annual report, the primary focus will be on growth and profitability. Anthropic generated $33.2 billion in revenue in the first three quarters of 2026, up approximately 1,200% year over year. However, sequential revenue growth slowed from 144% in the second quarter to 47% in the third quarter, and GAAP operating results also swung from a profit to a loss. The amount of incremental revenue added in the fourth quarter and whether operating profit can recover will be more indicative of shifts in demand around the IPO than full-year year-over-year growth.
By the second-quarter 2027 report, the primary focus will be on how much cash growth can retain. The prospectus shows that in the 12 months ending in late September 2027, Anthropic expects to pay approximately $70.7 billion in contractual payments. At that point, by evaluating first-half customer collections, computing expenditures, and free cash flow together, investors can more clearly determine whether revenue growth driven by Claude can cover the capital required for expansion.
This content was translated using AI and reviewed for clarity. It is for informational purposes only.
Recommended Articles












Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.